BIOLASE Technology, Inc. Names Richard Whipp Director of Operations

IRVINE, CA--(Marketwire - July 06, 2011) - BIOLASE Technology, Inc. (NASDAQ: BLTI), the World’s leading dental laser manufacturer and distributor, today announced that it has named veteran operations management executive Richard Whipp as Director of Operations, effective immediately. He will report to Chairman and CEO Federico Pignatelli and Chief Financial Officer Fred Furry.

Whipp, 59, has over 30 years of experience in manufacturing and operations. Prior to joining BIOLASE, Whipp spent 13 years in operations at Culver City, CA-based Discus Dental, a dental services and software division of Philips Electronics. Whipp was Senior Director of Operations at Discus Dental and was responsible for its manufacturing and distribution operations, with direct experience in diode laser supply chain management and lean manufacturing.

Pignatelli said, “Rick has the range of experience and expertise we need to manage our expanding production. We are experiencing very strong demand across our product platforms and Rick’s operations experience and managerial skills will be important in helping us improve our supply chain management and in coordinating our manufacturing operations as we continue to grow. We are pleased to welcome Rick to BIOLASE, and we look forward to working with him during this very exciting time for the Company.”

Prior to working at Discus Dental, Whipp worked from 1992-1998 at Torrance, CA-based Leica Geosystems, a manufacturer of high-tech marine navigation and survey GPS equipment. As the Director of Operations, he was responsible for all plant operations and managed all manufacturing, planning, purchasing, service, warehouse and logistics operations.

Whipp began his career in 1978 as a senior program planner and gradually worked his way into increasingly more responsible manufacturing management positions at such companies as Monrovia, CA-based Conrac Industries Inc. and Costa Mesa, CA-based Gulton Industries Inc.

About BIOLASE Technology, Inc.
BIOLASE Technology, Inc., the World’s leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment, products that are focused on technologies that advance the practice of dentistry and medicine. The Company’s laser products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE’s principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at http://www.biolase.com, Twitter at http://twitter.com/GoWaterlase, and YouTube at http://www.youtube.com/user/Rossca08.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “will,” and variations of these words or similar expressions. Forward-looking statements are based on management’s current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company’s actual results to differ materially from the statements contained herein, and are described in the Company’s reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.